PULSATILE DRUG DELIVERY SYSTEMS THE NOVEL APPROACH
DOI:
https://doi.org/10.22159/ijpps.2024v16i2.49960Keywords:
Circadian rhythm, Lag time, Ph, Pulsatile, Remotely controlledAbstract
Oral pulsatile drug delivery systems (PDDS) are intended to induce programmable lag phases before a quick and quantifiable, repeated, or prolonged medication release. As a result, they are gaining popularity due to their inherent suitability for achieving chronotherapeutic goals, which have just been highlighted concerning several prevalent chronic illnesses characterized by typical night or early-morning recurring symptoms (e. g. bronchial asthma, heart attack, rheumatoid arthritis, early-morningawakening). Furthermore, time-based colonic release is possible when pulsatile delivery devices are correctly modified to overcome unexpected gastric emptying and give delay periods that roughly match the small intestine transit time. Oral pulsatile administration is accomplished using several release platforms, including reservoir, capsular, and osmotic devices.
The current review article addressed the topics that followed: the reason pulsatile drug delivery systems have been invented; diseases for which pulsatile release is necessary; classification, advantages and disadvantages; methods used in the current systems; the situation nowadays and its potential for the future; recent advancements, and especially, the previous five to ten years of research on pulsatile drug delivery conducted by researchers using a variety of drugs for a variety of diseases.
Downloads
References
R Venkataswamy, Lavanya Nallaguntla. Review article on pulsatile drug delivery system. Asian J Pharm Clin Res. 2021 May;14(6):48-59. doi: 10.22159/ajpcr.2021.v14i6.41476.
Jain D, Raturi R, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011;1(1):57-65. doi: 10.4161/biom.1.1.17717, PMID 23507727, PMCID PMC3548250.
Maroni A, Zema L, Del Curto MD, Loreti G, Gazzaniga A. Oral pulsatile delivery: rationale and chronopharmaceutical formulations. Int J Pharm. 2010;398(1-2):1-8. doi: 10.1016/j.ijpharm.2010.07.026, PMID 20655998.
Mandal AS, Biswas N, Karim KM, Guha A, Chatterjee S, Behera M. Drug delivery system based on chronobiology-a review. J Control Release. 2010;147(3):314-25. doi: 10.1016/j.jconrel.2010.07.122, PMID 20691738.
Ghanei M, Nezhad LH, Harandi AA, Alaeddini F, Shohrati M, Aslani J. Combination therapy for airflow limitation in COPD. Daru. 2012;20(1):6. doi: 10.1186/2008-2231-20-6, PMID 23226113.
Mahajan KR, Ashish Prakash Gorle, Vijay Sanjay Khalane. Overview on pulsatile drug delivery system. Int J Sci Res Arch. 2022;5(2):110-8. doi: 10.30574/ijsra.2022.5.2.0067.
Sowmya P, Dp V, Nayek S. Pulsatile drug delivery system: a formulation approach for treatment of diseases. Int J Curr Pharm Sci. 2020 May;12(3):16-21. doi: 10.22159/ijcpr.2020v12i3.38328.
Kalantzi LE, Karavas E, Koutris EX, Bikiaris DN. Recent advances in oral pulsatile drug delivery. Recent Pat Drug Deliv Formul. 2009;3(1):49-63. doi: 10.2174/187221109787158337, PMID 19149729.
Pandit V, Kumar A, Ashawat MS, Verma CP, Kumar P. Recent advancement and technological aspects of pulsatile drug delivery system-a laconic review. Curr Drug Targets. 2017;18(10):1191-203. doi: 10.2174/1389450117666160208144343, PMID 26853323.
Patil SS, Shahiwala A. Patented pulsatile drug delivery technologies for chronotherapy. Expert Opin Ther Pat. 2014;24(8):845-56. doi: 10.1517/13543776.2014.916281, PMID 24810112.
Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release. 2009;134(2):74-80. doi: 10.1016/j.jconrel.2008.11.011, PMID 19105973.
Patel V, Soniwala M. Pulsatile drug delivery system for treatment of various inflammatory disorders: a review. Int J Drug Dev Res. 2012;4:67-87.
Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst. 2001;18(5):433-58. doi: 10.1615/CritRevTherDrugCarrierSyst. PMID 11763497.
Kumar PSSP, Srinivas L. A review on pulsatile drug delivery systems. Int J Pharm Sci Res. 2023;14(7):3246-54. doi: 10.13040/IJPSR.0975-8232.14(7).3246-54.
Sewlall S, Pillay V, Danckwerts MP, Choonara YE, Ndesendo VM, du Toit LC. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010;7(5):370-88. doi: 10.2174/156720110793566236, PMID 20950265.
Thakur G, Wani SUD, Gautam SP. A review on recent advancement in pulsatile drug delivery systems. Int J Curr Pharm Sci. 2021 Mar;12(2):6-10. doi: 10.22159/ijcpr.2021v13i2.41543.
Liu XM, Yang B, Wang Y, Wang J. New nanoscale pulsatile drug delivery system. Chem Mater. 2005;17(11):2792-95. doi: 10.1021/cm0479335.
Belgamwar V, Gaikwad M, Patil G, Surana S. Pulsatile drug delivery system. Asian J Pharm. 2008;2(3). doi: 10.4103/0973-8398.43297.
Fodor DM, Marta MM, Perju Dumbrava L. Implications of circadian rhythm in stroke occurrence: certainties and possibilities. Brain Sci. 2021;11(7):865. doi: 10.3390/brainsci11070865, PMID 34209758.
Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905. doi: 10.3390/molecules26195905, PMID 34641447.
Patil SS, Shahiwala A. Patented pulsatile drug delivery technologies for chronotherapy. Expert Opin Ther Pat. 2014;24(8):845-56. doi: 10.1517/13543776.2014.916281, PMID 24810112.
Arevalo Perez R, Maderuelo C, Lanao JM. Recent advances in colon drug delivery systems. J Control Release. 2020;327(v):703-24. doi: 10.1016/j.jconrel.2020.09.026, PMID 32941930.
Khan S, Monika. Circadian rhythms regulated asthma treatment by virtue of a pulsatile drug delivery system. Int J App Pharm. 2022 Jul;14(2):1-8. doi: 10.22159/ijap.2022v14i4.44395.
“National Institute of General Medical Sciences.” National Institute of General Medical Sciences (NIGMS). Available from: www.nigms.nih.gov/education/fact-sheets/Pages/circadianrhythms.aspx#:~:text=%E2%80%8B%E2%80%8BWhat%20are%20circadian,the%20study%20of%20circadian%20rhythms. [Last accessed 16 Nov 2023]
Reddy S, Reddy V, Sharma S. Physiology. In: Stat pearls. Treasure Island, (FL): Stat Pearls Publishing. Journal of Circadian Rhythms; 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519507. [Last accessed on 29 Dec 2023]
Mokkawes T, De Visser T, Cao Y, De Visser SP. Melatonin activation by human cytochrome P450 enzymes: a comparison between different isozymes. Molecules. 2023;28(19):6961. doi: 10.3390/molecules28196961, PMID 37836804.
BaHammam AS, Pirzada A. Timing matters: the interplay between early mealtime, circadian rhythms, gene expression, circadian hormones, and metabolism-a narrative review. Clocks Sleep. 2023;5(3):507-35. doi: 10.3390/clockssleep5030034, PMID 37754352.
Mahajan NM, Danao KR, Pawde GN. Formulation and evaluation of chronomodulated pulsatile therapeutic system for early morning surge in blood pressure gangane, ps. Int J Pharm Pharm Sci. 2015;7(6):337-41.
Battu S, Yalavarthi PR, Gopireddy VSR, Vattikuti UMR, Devi J, Vadlamudi HC. Chronopharmacokinetic evaluation of budesonide multi particulate systems. Recent Pat Drug Deliv Formul. 2017;11(3):221-9. doi: 10.2174/1872211312666171213113127, PMID 29237390.
Nikam S, Jadhav P, Chaudhari B, Velhal A. Pulsatile delivery of drug for a range of diseases. Asian J Res Pharm Sci. 2022 Nov:329-34. doi: 10.52711/2231-5659.2022.00056.
Mastiholimath VS, Dandagi PM, Jain SS, Gadad AP, Kulkarni AR. Time and pH-dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma. Int J Pharm. 2007;328(1):49-56. doi: 10.1016/j.ijpharm.2006.07.045, PMID 16942847.
Mahajan A, Pancholi S. Pulsatile drug delivery for the treatment of nocturnal asthma: a chronopharmaceutical approach. Lat Am J Pharm. 2010;29:305-11.
Tekade AR, Gattani SG. Development and evaluation of pulsatile drug delivery system using novel polymer. Pharm Dev Technol. 2009;14(4):380-7. doi: 10.1080/10837450802712625, PMID 19235549.
Drugs for GERD and peptic ulcer disease. Med Lett Drugs Ther. 2022;64:49-56. PMID 35348552.
Histamine type-2 receptor antagonists (H2 Blockers). Liver Tox: Clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Available from: http://www.ncbi.nlm.nih.gov/books/NBK547929/.
Malladi M, Jukanti R. Floating pulsatile drug delivery system of famotidine: design, statistical optimization, and in vitro evaluation. Int J Pharm Pharm Sci. 2016;8(5):169-81.
Shaik A, DN. Formulation and in vitro evaluation of floating pulsatile drug delivery of chronotherapeutic release of h2 receptor antagonist of famotidine. Int J Pharm Drug Anal. 2016;11(3)86-91. doi: 10.47957/ijpda.v11i3.558.
Jagdale SC, Suryawanshi VM, Pandya SV, Kuchekar BS, Chabukswar AR. Development of press-coated, floating-pulsatile drug delivery of lisinopril. Sci Pharm. 2014;82(2):423-40. doi: 10.3797/scipharm.1301-27, PMID 24959410.
Yadav YS, Vishwakarma AK, Yadav VK, Yadav RK, Yadav P. Importance of SR-B1 receptor in carcinogenesis and treatment: a review. Int J Pharm Sci Res. 2017;8(4):1820-5. doi: 10.13040/IJPSR.0975-8232.8(4).1820-25.
Bajpai M, Singh DC, Bhattacharya A, Singh A. Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium. Indian J Pharm Sci. 2012;74(2):101-6. doi: 10.4103/0250-474X.103839, PMID 23325989.
Bailes BK. Diabetes mellitus and its chronic complications. AORN J. 2002;76(2):265-82. doi: 10.1016/S0001-2092(06)61065-X, PMID 12194653.
Harreiter J, Roden M. Diabetes mellitus-definition, classification, diagnosis, screening and prevention. Wien Klin Wochenschr. 2019;131Suppl 1:6-15. doi: 10.1007/s00508-019-1450-4, PMID 30980151.
Singh S, Koland M. Formulation and evaluation of pulsatile drug delivery systems of glipizide for the management of type-Ii diabetes mellitus. J Drug Delivery Ther. 2016;6(1):11-8. doi: 10.22270/jddt.v6i1.1192.
Satin LS, Butler PC, Ha J, Sherman AS. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Mol Aspects Med. 2015;42:61-77. doi: 10.1016/j.mam.2015.01.003, PMID 25637831.
Xia AY, Zhu H, Zhao ZJ, Liu HY, Wang PH, Ji LD. Molecular mechanisms of the melatonin receptor pathway linking circadian rhythm to type 2 diabetes mellitus. Nutrients. 2023;15(6):1406. doi: 10.3390/nu15061406, PMID 36986139.
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023-38. doi: 10.1016/S0140-6736(16)30173-8.
Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells. 2021;10(11):2857. doi: 10.3390/cells10112857, PMID 34831081.
Qureshi J, Ahuja A, Baboota S, Chutani K, Jain S, Ali J. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis. Methods Find Exp Clin Pharmacol. 2009;31(1):15-23. doi: 10.1358/mf.2009.31.1.1338412, PMID 19357794.
El-Hady SM, AbouGhaly MHH, El-Ashmoony MM, Helmy HS, El-Gazayerly ON. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. Int J Pharm. 2020;576:118982. doi: 10.1016/j.ijpharm.2019.118982, PMID 31870958.
El-Maradny Hoda A. Modulation of a pulsatile release drug delivery system using different swellable/rupturable materials. Drug Deliv. 2007;14(8):539-46. doi: 10.1080/10717540701606574, PMID 18027184.
Giebfried J, Lorentz A. Relationship between the biological clock and inflammatory bowel disease. Clocks Sleep. 2023;5(2):260-75. doi: 10.3390/clockssleep5020021, PMID 37218867.
Akilandeshwari AL, Elango K, Chellakumari SD, Kumar SK. Design, development and evaluation of pulsatile drug delivery system of ramipril. Res J Pharm Dosage Form Tech. 2014;6(4):235-42.
Hartz J, Clauss S. Treatment strategies for hypercholesterolemia. Curr Pediatr Rev. 2017;13(4):243-54. doi: 10.2174/1573396314666180111143900, PMID 29332588.
Civeira F, Arca M, Cenarro A, Hegele RA. A mechanism-based operational definition and classification of hypercholesterolemia. J Clin Lipidol. 2022;16(6):813-21. doi: 10.1016/j.jacl.2022.09.006, PMID 36229375.
Kumari PVK. Formulation and in vitro evaluation of compressed coated tablets of simvastatin for pulsatile drug delivery: pharmaceutical science-pharmaceutics for effective drug dosage. International Journal of Life Science and Pharma Research. 2021;11(1):110-7. doi: 10.22376/ijpbs/lpr.2021.11.1. P110-117.
Wang JJ, Lei KF, Han F. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Med Pharmacol Sci. 2018;22(12):3855-64. doi: 10.26355/eurrev_201806_15270, PMID 29949179.
Ghosh S, Ganguly D, Majumder S. A review on pharmacological and therapeutic Insight of ozanimod for colon disease in nano-structure. Int J Pharm Pharm Sci. 2022;14(4):13-9. doi: 10.22159/Ijpps.2022v14i4.44150.
GVB. Pulsatile drug delivery: a strategy for treating chronotherapeutic ailments. Int J Curr Pharm Sci. 2023;15(4):1-8. doi: 10.22159/ijcpr.2023v15i4.3012.
Vaja PN, Detroja CM. Formulation of mesalamine-loaded rectal mucoadhesive pellets for the treatment of inflammatory bowel disease using 32 full factorial design. Int J App Pharm. 2022:14(5)88-94. doi: 10.22159/ijap.2022v14i5.45180.
Olarescu NC, Gunawardane K, Hansen TK. Normal physiology of growth hormone in adults. In: Feingold KR, Anawalt B, Blackman MR. editors. South Dartmouth. Text. Com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279056. [Last accessed on 29 Dec 2023]
Lu M, Flanagan JU, Langley RJ, Hay MP, Perry JK. Targeting growth hormone function: strategies and therapeutic applications. Signal Transduct Target Ther. 2019;4(1):3. doi: 10.1038/s41392-019-0036-y, PMID 30775002.
Sopyan I, Komarudin ADP, Huang JA, KS IS. An overview: development of colon drug delivery system and its application and limitations. Int J App Pharm. 2023;15(1):24-30. doi: 10.22159/ijap.2023v15i1.46681.
Yehia SA, Elshafeey AH, Elsayed I. Pulsatile systems for colon targeting of budesonide: in vitro and in vivo evaluation. Drug Deliv. 2011;18(8):620-30. doi: 10.3109/10717544.2011.621987, PMID 22111975.
Battu S, Yalavarthi PR, Gopireddy VSR, Vattikuti UMR, Devi J, Vadlamudi HC. Chronopharmacokinetic evaluation of budesonide multiparticulate systems. Recent Pat Drug Deliv Formul. 2017;11(3):221-9. doi: 10.2174/1872211312666171213113127, PMID 29237390.
Fodor DM, Marta MM, Perju Dumbrava L. Implications of circadian rhythm in stroke occurrence: certainties and possibilities. Brain Sci. 2021;11(7):865. doi: 10.3390/brainsci11070865, PMID 34209758.
Sinha VR, Bhinge JR, Kumria R, Kumar M. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Deliv. 2006;13(3):221-5. doi: 10.1080/10717540500309180, PMID 16556575.
Ioniuc I, Miron I, Lupu VV, Starcea IM, Azoicai A, Alexoae M. Challenges in the pharmacotherapeutic management of pediatric asthma. Pharmaceuticals (Basel). 2022;15(12):1581. doi: 10.3390/ph15121581, PMID 36559032.
Mahajan A, Pancholi S. Pulsatile drug delivery for the treatment of nocturnal asthma: a chronopharmaceutical approach. Lat Am J Pharm. 2010;29:153-6.
Agache I, Eguiluz Gracia I, Cojanu C, Laculiceanu A, Del Giacco S, Zemelka-Wiacek M. Advances and highlights in asthma in 2021. Allergy. 2021;76(11):3390-407. doi: 10.1111/all.15054, PMID 34392546.
Miller RL, Grayson MH, Strothman K. Advances in asthma: new understandings of asthma’s natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol. 2021;148(6):1430-41. doi: 10.1016/j.jaci.2021.10.001, PMID 34655640.
Gans MD, Gavrilova T. Understanding the immunology of asthma: pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr Respir Rev. 2020;36(v):118-27. doi: 10.1016/j.prrv.2019.08.002, PMID 31678040.
World Health Organisations (WHO) asthma. Available from: https://www.who.int/news-room/fact-sheets/detail/asthma#:~:text=Asthma%20is%20a%20chronic%20lung,come%20and%20go%20over%20time.
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204-22. doi: 10.1016/S0140-6736(20)30925-9, PMID 33069326.
The Global Asthma Report 2022. Int J Tuberc Lung Dis Off J Int Union Against Tuberc Lung Dis. 2022;26(1):1-104. doi: 10.5588/ijtld.22.1010.
Chung KF, Dixey P, Abubakar Waziri H, Bhavsar P, Patel PH, Guo S. Characteristics, phenotypes, mechanisms and management of severe asthma. Chin Med J (Engl). 2022;135(10):1141-55. doi: 10.1097/CM9.0000000000001990, PMID 35633594.
Khan S, Monika. Circadian rhythms regulated asthma treatment by virtue of pulsatile drug delivery system. Int J App Pharm. Jul 2022;14(4):1-8. doi: 10.22159/ijap.2022v14i4.44395.
R Venkataswamy, Lavanya Nallaguntla. Review article on pulsatile drug delivery system. Asian J Pharm Clin Res. 2021 May;14(6):48-59. doi: 10.22159/ajpcr.2021.v14i6.41476.
Jain D, Raturi R, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011;1(1):57-65. doi: 10.4161/biom.1.1.17717, PMID 23507727.
Pandit V, Kumar A, Ashawat MS, Verma CP, Kumar P. Recent advancement and technological aspects of pulsatile drug delivery system-a laconic review. Curr Drug Targets. 2017;18(10):1191-203. doi: 10.2174/1389450117666160208144343, PMID 26853323.
Hiral CD, Rakshit SN, Prajapati AP, Patel MM. Formulation and evaluation of modified pulsincap as pulsatile drug delivery system for treatment of rheumatoid arthritis. PCI-Approved-IJPSN. 2016;9(5):3476-87. doi: 10.37285/ijpsn.2016.9.5.5.
Kumar A, Kumar Gautam G, BSS. Development, optimization and evaluation of pulsatile drug delivery capsules loaded with carvedilol by applying quality by design. Int J App Pharm. 2022 Jan;14(1):213-20. doi: 10.22159/ijap.2022v14i1.43146.
Karale P, Diksha K, Pande V. Pros and cons of pulsatile drug delivery system. Int J Pharm Drug Anal. 2015;3(8):255-60. https://www.ijpda.com/index.php/journal/article/view/166.
Jaiswal H, Ansari VA, Pandit JN, Ahsan F. Pulsatile drug delivery system: an overview with special emphasis on losartan and captopril. Res J Pharm Technol. 2019;12(7):3175. doi: 10.5958/0974-360X.2019.00535.3.
Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: current perspectives. J Control Release. 2009;134(2):74-80. doi: 10.1016/j.jconrel.2008.11.011, PMID 19105973.
Maroni A, Zema L, Del Curto MD, Loreti G, Gazzaniga A. Oral pulsatile delivery: rationale and chronopharmaceutical formulations. Int J Pharm. 2010;398(1-2):1-8. doi: 10.1016/j.ijpharm.2010.07.026, PMID 20655998.
Pandit V, Kumar A, Ashawat MS, Verma CP, Kumar P. Recent advancement and technological aspects of pulsatile drug delivery system-a laconic review. Curr Drug Targets. 2017;18(10):1191-203. doi: 10.2174/1389450117666160208144343, PMID 26853323.
Khalifa AZ, Zyad H, Mohammed H, Ihsan K, Alrawi L, Abdullah M. Recent advances in remotely controlled pulsatile drug delivery systems. J Adv Pharm Technol Res. 2022 Apr-Jun;13(2):77-82. doi: 10.4103/japtr.japtr_330_21, PMID 35464664, PMCID PMC9022360.
Pandit V, Kumar A, Ashawat MS, Verma CP, Kumar P. Recent advancement and technological aspects of pulsatile drug delivery system-a laconic review. Curr Drug Targets. 2017;18(10):1191-203. doi: 10.2174/1389450117666160208144343, PMID 26853323.
Kwon K, Kim JU, Won SM, Zhao J, Avila R, Wang H. A battery-less wireless implant for the continuous monitoring of vascular pressure, flow rate and temperature. Nat Biomed Eng. 2023;7(10):1215-28. doi: 10.1038/s41551-023-01022-4, PMID 37037964.
Lee SH, Ahn JW, Cho YC, Kim SN, Lee C, Ku GW. Wirelessly controlled implantable system for On-Demand and pulsatile insulin administration. Sci Rep. 2019;9(1):5009. doi: 10.1038/s41598-019-41430-8, PMID 30899066.
Rosinko M. Safety processor for wireless control of a drug delivery device; 2016. US9486571B2. Available from: https://patents.google.com/patent/US9486571B2/en. [Last accessed on 29 Dec 2023]
Farra R, Sheppard NF, McCabe L, Neer RM, Anderson JM, Santini JT. First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med. 2012;4(122):122ra21. doi: 10.1126/scitranslmed.3003276, PMID 22344516.
Ashton MD, Appen IC, Firlak M, Stanhope NE, Schmidt CE, Eisenstadt WR. Wirelessly triggered bioactive molecule delivery from degradable electroactive polymer films. Polym Int. 2021;70(4):467-74. doi: 10.1002/pi.6089.
Kwon IC, Bae YH, Kim SW. Electrically erodible polymer gel for controlled release of drugs. Nature. 1991;354(6351):291-3. doi: 10.1038/354291a0, PMID 1956379.
Kim SY, Lee YM. Drug release behavior of electrical responsive poly(vinyl alcohol)/poly(acrylic acid) IPN hydrogels under an electric stimulus. J Appl Polym Sci. 1999;74(7):1752-61. doi: 10.1002/(SICI)1097-4628(19991114)74:7<1752::AID-APP18>3.0.CO;2-H.
Neumann SE, Chamberlayne CF, Zare RN. Electrically controlled drug release using pH-sensitive polymer films. Nanoscale. 2018;10(21):10087-93. doi: 10.1039/C8NR02602E, PMID 29781009.
Mohapatra A, Wells C, Jennings A, Ghimire M, Mishra SR, Morshed BI. Electric stimulus-responsive chitosan/MNP composite microbeads for a drug delivery system. IEEE Trans Biomed Eng. 2020;67(1):226-33. doi: 10.1109/TBME.2019.2911579, PMID 30998454.
Pelliccioli AP, Wirz J. Photoremovable protecting groups: reaction mechanisms and applications. Photochem Photobiol Sci. 2002;1(7):441-58. doi: 10.1039/b200777k, PMID 12659154.
Wang H, Zhang W, Gao C. Shape transformation of light-responsive pyrene-containing micelles and their influence on cytoviability. Biomacromolecules. 2015;16(8):2276-81. doi: 10.1021/acs.biomac.5b00497, PMID 26133965.
Lu J, Choi E, Tamanoi F, Zink JI. Light‐activated nanoimpeller‐controlled drug release in cancer cells. Small. 2008;4(4):421-6. doi: 10.1002/smll.200700903, PMID 18383576.
Gandhi A, Paul A, Sen SO, Sen KK. Studies on thermoresponsive polymers: phase behaviour, drug delivery and biomedical applications. Asian J Pharm Sci. 2015;10(2):99-107. doi: 10.1016/j.ajps.2014.08.010.ajps.2014.08.010.
Lin SY. Thermoresponsive gating membranes embedded with liquid crystal(s) for pulsatile transdermal drug delivery: an overview and perspectives. J Control Release. 2020;319:450-74. doi: 10.1016/j.jconrel.2019.12.046, PMID 31901369.
Tachibana K, Tachibana Shunro. The use of ultrasound for drug delivery. Echocardiography. 2001;18(4):323-8. doi: 10.1046/j.1540-8175.2001.00323.x, PMID 11415505.
Jain A, Tiwari A, Verma A, Jain SK. Ultrasound-based triggered drug delivery to tumors. Drug Deliv Transl Res. 2018;8(1):150-64. doi: 10.1007/s13346-017-0448-6, PMID 29204925.
Sirsi SR, Borden MA. State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev. 2014;72:3-14. doi: 10.1016/j.addr.2013.12.010, PMID 24389162.
Abbott JG. Rationale and derivation of MI and TI-a review. Ultrasound Med Biol. 1999;25(3):431-41. doi: 10.1016/S0301-5629(98)00172-0, PMID 10374986.
Baker KG, Robertson VJ, Duck FA. A review of therapeutic ultrasound: biophysical effects. Phys Ther. 2001;81(7):1351-8. doi: 10.1093/ptj/81.7.1351, PMID 11444998.
Ciancia S, Cafarelli A, Zahoranova A, Menciassi A, Ricotti L. Pulsatile drug delivery system triggered by acoustic radiation force. Front Bioeng Biotechnol. 2020;8:317. doi: 10.3389/fbioe.2020.00317, PMID 32411680.
Sewlall S, Pillay V, Danckwerts MP, Choonara YE, Ndesendo VM, du Toit LC. A timely review of state-of-the-art chronopharmaceuticals synchronized with biological rhythms. Curr Drug Deliv. 2010;7(5):370-88. doi: 10.2174/156720110793566236, PMID 20950265.
Timko BP, Dvir T, Kohane DS. Remotely triggerable drug delivery systems. Adv Mater. 2010;22(44):4925-43. doi: 10.1002/adma.201002072, PMID 20818618.
Fodor DM, Marta MM, Perju Dumbrava L. Implications of circadian rhythm in stroke occurrence: certainties and possibilities. Brain Sci. 2021;11(7):865. doi: 10.3390/brainsci11070865, PMID 34209758.
Ciancia S, Cafarelli A, Zahoranova A, Menciassi A, Ricotti L. Pulsatile drug delivery system triggered by acoustic radiation force. Front Bioeng Biotechnol. 2020;8:317. doi: 10.3389/fbioe.2020.00317, PMID 32411680.
McDonagh T, Belton P, Qi S. Manipulating drug release from 3D printed dual-drug loaded polypills using challenging polymer compositions. Int J Pharm. 2023;637:122895. doi: 10.1016/j.ijpharm.2023.122895, PMID 36972779.
Parekh K, Thakkar V, Joshi A, Sojitra C, Dalwadi S, Rana H. Optimizing pulsatile release of febuxostat for managing gout flares: a chronotherapeutic approach. Futur J Pharm Sci. 2023;9(1):89. doi: 10.1186/s43094-023-00542-9.
Vemula SK, Daravath B, Gummadi SB, Repka M. Formulation and development of flurbiprofen colon-specific Eudragit coated Matrix tablets: use of a novel crude banana peel powder as a time-dependent polymer. AAPS PharmSciTech. 2023;24(7):189. doi: 10.1208/s12249-023-02646-0, PMID 37726501.
Rashid R, Zaman M, Ahmad M, Khan MA, Butt MH, Salawi A. Press-coated aceclofenac tablets for pulsatile drug delivery: formulation and in vitro evaluations. Pharmaceuticals (Basel). 2022;15(3):326. doi: 10.3390/ph15030326, PMID 35337124.
Poonuru RR, Penala A. Development and characterization of bimodal chrono modulated drug delivery of methylphenidate hydrochloride. Food Hydrocoll Health. 2023;3:100127. doi: 10.1016/j.fhfh.2023.100127.
Sreeharsha N, Naveen NR, Anitha P, Goudanavar PS, Ramkanth S, Fattepur S. Development of nanocrystal compressed minitablets for chronotherapeutic drug delivery. Pharmaceuticals (Basel). 2022;15(3):311. doi: 10.3390/ph15030311, PMID 35337109.
Li R, Pan Y, Chen D, Xu X, Yan G, Fan T. Design, preparation and in vitro evaluation of core–shell fused deposition modelling 3D-printed verapamil hydrochloride pulsatile tablets. Pharmaceutics. 2022;14(2):437. doi: 10.3390/pharmaceutics14020437, PMID 35214169.
Broesder A, Bircan SY, de Waard AB, Eissens AC, Frijlink HW, Hinrichs WLJ. Formulation and in vitro evaluation of pellets containing sulfasalazine and caffeine to verify ileo-colonic drug delivery. Pharmaceutics. 2021;13(12):1985. doi: 10.3390/pharmaceutics13121985, PMID 34959267.
Roy SKr, Das P, Mondal A, Mandal A, Kuotsu K. Design, formulation and evaluation of multiparticulate time programmed system of ramipril for pulsed release: an approach in the management of early Morning surge in blood pressure. J Drug Deliv Sci Technol. 2021;62:102344. doi: 10.1016/j.jddst.2021.102344.
Gowthami B, Krishna SVG, Rao DS. Formulation of tablets in capsule system: statistical optimization for chronotherapeutic drug delivery of propranolol hydrochloride. J Drug Deliv Sci Technol. 2021;63:102398. doi: 10.1016/j.jddst.2021.102398.
Reddy Dumpa N, Bandari S, A Repka M. Novel gastroretentive floating pulsatile drug delivery system produced via hot-melt extrusion and fused deposition modeling 3d printing. Pharmaceutics. 2020;12(1):52. doi: 10.3390/pharmaceutics12010052, PMID 31936212.
Jagdale SC, Suryawanshi VM, Pandya SV, Kuchekar BS, Chabukswar AR. Development of press-coated, floating-pulsatile drug delivery of lisinopril. Sci Pharm. 2014;82(2):423-40. doi: 10.3797/scipharm.1301-27, PMID 24959410.
Moutaharrik S, Maroni A, Melocchi A, Zema L, Foppoli A, Cerea M. Oral colon delivery platform based on a novel combination approach: design concept and preliminary evaluation. J Drug Deliv Sci Technol. 2021;66:102919. doi: 10.1016/j.jddst.2021.102919.
El-Hady SM, AbouGhaly MHH, El-Ashmoony MM, Helmy HS, El-Gazayerly ON. Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. Int J Pharm. 2020;576:118982. doi: 10.1016/j.ijpharm.2019.118982, PMID 31870958.
Zhou Y, Li L, Liu Z, Wang Q, Zhou Q, Zhou W. Development and evaluation of zopiclone compression coated tablet for time-controlled pulse release: mechanism and in vivo study. J Drug Deliv Sci Technol. 2020;57:101714. doi: 10.1016/j.jddst.2020.101714.
Othman AI, Amin MM, Abu-Elyazid SK, Abdelbary GA. Trimetazidine dihydrochloride pulsatile–release tablets for the treatment of morning anginal symptoms: dual optimization, characterization and pharmacokinetic evaluation. Curr Drug Deliv. 2021;18(8):1182-96. doi: 10.2174/1567201818666210212095932, PMID 33583377.
Desai N, Purohit R. Development of novel high density gastroretentive multiparticulate pulsatile tablet of clopidogrel bisulfate using quality by design approach. AAPS PharmSciTech. 2017;18(8):3208-18, doi: 10.1208/s12249-017-0805-2, PMID 28550603.
Patadia R, Vora C, Mittal K, Mashru RC. Quality by design empowered development and optimisation of time-controlled pulsatile release platform formulation employing compression coating technology. AAPS PharmSciTech. 2017;18(4):1213-27, doi: 10.1208/s12249-016-0590-3, PMID 27460936.
Reddy Dumpa N, Bandari S, A Repka M. Novel gastroretentive floating pulsatile drug delivery system produced via hot-melt extrusion and fused deposition modeling 3D printing. Pharmaceutics. 2020;12(1):52. doi: 10.3390/pharmaceutics12010052, PMID 31936212.
Giri S, Mohapatra S. Formulation and in vitro characterization of time release tablets of propranolol hydrochloride. Indian J Pharm Sci. 2020;82(2):216-21. doi: 10.36468/pharmaceutical-sciences.641.
Hussein M, Nathir I. Pulsatile drug delivery system utilizing innovative technology. Pak J Med Health Sci. 2022;16(6):601-6. doi: 10.53350/pjmhs22166601.
Yadav R, Jha M, Jat D, Jain DK. Present scenario of pulsatile drug delivery system. IJCAAP. 2023;7(4):171-8. doi: 10.18231/j.ijcaap.2022.035.
Khan S, Monika. Circadian rhythms regulated asthma treatment by virtue of pulsatile drug delivery system. Int J App Pharm. 2022 Jul;14(4):1-8. doi: 10.22159/ijap.2022v14i4.44395.
Vemula SK, Katkum R. Colon-specific double-compression coated pulsatile tablets of ketorolac tromethamine: formulation development and pharmacokinetics. J Drug Deliv Sci Technol. 2015;29:78-83. doi: 10.1016/j.jddst.2015.06.009.
Kaljevic O, Djuris J, Djuric Z, Ibric S. Application of failure mode and effects analysis in quality by design approach for formulation of carvedilol compression coated tablets. J Drug Deliv Sci Technol. 2016;32(Apr):56-63. doi: 10.1016/j.jddst.2016.02.004.
Maeda H, Ogawa Y, Ishiyama M, Hirayama T, Terada K. Formulation approach for nicorandil pulsatile release tablet. Chem Pharm Bull (Tokyo). 2008;56(4):464-67. doi: 10.1248/cpb.56.464, PMID 18379091.
Kuril A, Ambekar A, Nimase B, Giri P, Nikam P, Desai H. Exploring the potential of 3d printing in pharmaceutical development. Int J Curr Pharm Sci. 2023 Nov;15(6):31-42. doi: 10.22159/ijcpr.2023v15i6.3085.
Published
How to Cite
Issue
Section
Copyright (c) 2024 VISHAL BODKE, BHARAT W. TEKADE, RUCHITA BADEKAR, SWAPNIL D. PHALAK, MOHAN KALE
This work is licensed under a Creative Commons Attribution 4.0 International License.
